Louisiana 2019 Regular Session

Louisiana House Bill HB237

Introduced
3/27/19  
Refer
3/27/19  

Caption

Prohibits preexisting condition exclusions or other discrimination based on health status (OR NO IMPACT See Note)

Impact

The proposed law aims to transform health insurance availability in Louisiana by guaranteeing coverage and preventing insurers from denying applications based on health status-related factors such as medical conditions, claims experience, and genetic information. This change is expected to facilitate access to necessary health services for a broader range of individuals, including those who previously faced barriers to coverage due to their health conditions. By ensuring that essential health benefits are included, the bill also aims to uphold the quality of healthcare services received by policyholders.

Summary

House Bill 237 seeks to establish comprehensive protections against discrimination based on health status in Louisiana's health insurance market. The bill explicitly prohibits group health plans and health insurance issuers from imposing preexisting condition exclusions and mandates the acceptance of all applicants for coverage. This is a significant move towards ensuring equitable access to health insurance for all individuals, especially those with existing health issues, thereby enhancing health care portability and availability across the state.

Sentiment

The sentiment surrounding the bill appears to be generally favorable among supporters who advocate for broader access to health care and protections against discrimination by insurance companies. Proponents argue that this bill aligns with national efforts to increase healthcare access while ensuring that health status does not prevent individuals from obtaining insurance. However, concerns have been expressed regarding the potential financial implications for insurance issuers and the broader healthcare system, with opponents cautioning about the sustainability of such requirements on premiums and service availability.

Contention

Despite the enthusiasm from proponents, the bill is not without contention. Critics emphasize that while the goals are commendable, there may be ramifications for insurance companies that could lead to increased costs passed onto consumers. They argue that the lack of preexisting condition exclusions could motivate unhealthy individuals to delay health care until after they obtain coverage, potentially skewing risk pools. This aspect of the debate highlights the ongoing challenge of balancing equitable access to healthcare while ensuring the economic viability of health insurance providers.

Companion Bills

No companion bills found.

Previously Filed As

LA HB594

Provides relative to reimbursement rates for certain ventilation treatments

LA HB235

Provides relative to the guaranteed issue of Medicare supplement policies

LA HB622

Requires health insurance coverage for histotripsy procedures (OR INCREASE GF EX See Note)

LA HB408

Provides relative to group health insurance renewals

LA HB264

Provides for the utilization of pharmaceutical rebates by a pharmacy benefit manager (OR +$34,237,688 SG EX See Note)

LA HB6

Exempts Louisiana residents from the assessment of penalties for noncompliance with the Patient Protection and Affordable Care Act (EG NO IMPACT See Note)

LA HB428

Provides for unfair trade practices by insurers and pharmacy benefit managers

LA HB188

Provides for review of fees charged for external review

Similar Bills

LA HB717

Provides for conditions and prohibitions during withdrawal from health insurance markets in this state

LA SB174

Provides technical changes in references to federal law regarding health insurance. (8/1/20)

IL SB3130

INSURANCE-VARIOUS

NJ A5383

Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

NJ S3831

Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.

NJ A5000

Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.

NJ S4294

Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

NJ A4646

Requires Medicaid coverage for self-administered hormonal contraceptives dispensed by pharmacist under standing order.